N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide

C19H20N6O2 — CID 646319

IUPACN-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide
SMILESO=C(Cn1nnc(-c2ccccc2)n1)Nc1ccccc1N1CCOCC1
InChIInChI=1S/C19H20N6O2/c26-18(14-25-22-19(21-23-25)15-6-2-1-3-7-15)20-16-8-4-5-9-17(16)24-10-12-27-13-11-24/h1-9H,10-14H2,(H,20,26)
InChIKeyQJLJSKOPIGOTBR-UHFFFAOYSA-N
MW364.41 g/mol
LogP1.82
Rot. Bonds5

About N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide

N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide (PubChem CID 646319) has the molecular formula C19H20N6O2 and a molecular weight of 364.41 g/mol. Its IUPAC name is N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide.

Molecular Properties

Compound NameN-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide
PubChem CID646319
Molecular FormulaC19H20N6O2
Molecular Weight364.41 g/mol
Exact Mass364.16
IUPAC NameN-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide
SMILESO=C(Cn1nnc(-c2ccccc2)n1)Nc1ccccc1N1CCOCC1
InChIInChI=1S/C19H20N6O2/c26-18(14-25-22-19(21-23-25)15-6-2-1-3-7-15)20-16-8-4-5-9-17(16)24-10-12-27-13-11-24/h1-9H,10-14H2,(H,20,26)
InChIKeyQJLJSKOPIGOTBR-UHFFFAOYSA-N
XLogP1.82
TPSA85.17 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500364.41
LogP ≤ 51.82
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-(3,3-Diphenylpropyl)-3-[3-(2-methyltetrazol-5-yl)phenyl]-1-(2-morpholin-4-ylethyl)urea
CID 16736327
N-(2-Morpholin-4-yl-phenyl)-2-(5-p-tolyl-tetrazol-2-yl)-acetamide
CID 644884
N-(2,6-Dimethyl-phenyl)-2-[5-(4-morpholin-4-yl-phenyl)-tetrazol-2-yl]-acetamide
CID 645326
1-(3,4-Dihydro-2H-quinolin-1-yl)-2-[5-(4-morpholin-4-ylmethyl-phenyl)-tetrazol-2-yl]-ethanone
CID 646381
[5-(4-Morpholin-4-yl-phenyl)-tetrazol-2-yl]-acetic acid cyclohexyl ester
CID 646384
2-[5-[4-(dimethylamino)phenyl]-2-tetrazolyl]-N-[2-(4-morpholinyl)phenyl]acetamide
CID 646660
N-(2,5-dimethylphenyl)-2-[5-(4-morpholin-4-ylphenyl)tetrazol-2-yl]acetamide
CID 1136633
2-[5-[4-(morpholin-4-ylmethyl)phenyl]tetrazol-2-yl]-N,N-diphenylacetamide
CID 1157274
1-(4-fluorophenyl)-4-[(5-phenyl-2H-tetrazol-2-yl)acetyl]piperazine
CID 1264121
N-(2,6-dimethylphenyl)-2-[5-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]tetrazol-2-yl]acetamide
CID 1462999
2-[5-(2-fluorophenyl)-2H-tetrazol-2-yl]-N-[4-(4-morpholinylcarbonyl)phenyl]acetamide
CID 2224231
4-{4-[2-(5-Phenyl-tetrazol-2-yl)-acetylamino]-phenyl}-piperazine-1-carboxylic acid tert-butyl ester
CID 6603560

Frequently Asked Questions

What is the IUPAC name of N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide?
The IUPAC name of N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide (CID 646319) is N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide.
What is the SMILES notation for N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide?
The canonical SMILES for N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide is O=C(Cn1nnc(-c2ccccc2)n1)Nc1ccccc1N1CCOCC1.
What is the InChIKey of N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide?
The InChIKey is QJLJSKOPIGOTBR-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20N6O2/c26-18(14-25-22-19(21-23-25)15-6-2-1-3-7-15)20-16-8-4-5-9-17(16)24-10-12-27-13-11-24/h1-9H,10-14H2,(H,20,26).
What are the key properties of N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide?
N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide has a molecular weight of 364.41 g/mol, XLogP of 1.82, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-morpholin-4-ylphenyl)-2-(5-phenyltetrazol-2-yl)acetamide is sourced from PubChem (CID 646319), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).